http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2009005341-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 2007-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1229204194dce1238e61f431002158ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc05f4d90e485aacb41418102753ceb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2af557e3e978abc51b41c9b896535551
publicationDate 2009-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2009005341-A
titleOfInvention TRANSDERMAL THERAPEUTIC SYSTEM TO ADMINISTER THE BUPRENORFINE ACTIVE SUBSTANCE.
abstract The invention relates to a transdermal therapeutic system for administering the active substance buprenorphine; said system comprises at least one carboxylic acid that determines the solubility of buprenorphine in the matrix layer and which can also be absorbed; The transdermal therapeutic system according to the invention is used in the treatment of pain and is characterized by a considerably increased use of the active substance.
priorityDate 2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990

Total number of triples: 28.